Clinical trial
Blood Pressure Control to Reduce Renal Risk for Type 2 Diabetes Mellitus
NCT03477786 is registered in ClinicalTrials.gov with National Health Research Institutes, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blood Pressure Control to Reduce Renal Risk for Type 2 Diabetes Mellitus
- Lead sponsor
- National Health Research Institutes, Taiwan
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 28, 2013
- Completion date
- December 31, 2023
- Enrollment
- 1,500 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hypertension, type 2 diabetes mellitus